The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Trump administration aims to boost farming, medical innovation with streamlined biotech rules

| | October 9, 2019

Trump administration officials say they are committed to reducing regulatory barriers to agricultural biotechnology as part of a larger strategy to promote the development of a “bioeconomy” based on far-reaching scientific innovations that could revolutionize medicine, nutrition and manufacturing as well as farming.

Agricultural biotech “should be the leading area for the bioeconomy, almost by definition,” Andrew Olmem, deputy director for the National Economic Council said Monday at an all-day White House “Summit on America’s Bioeconomy.” “Farmers are really since day one the cutting edge of American technology.”

Michael Kratsios, the White House’s chief technology officer, noted that the administration issued an executive order in June ordering federal agencies to find ways that they can streamline the regulation of biotech crops and animals to focus the approval process on products that could pose an environmental or health risk.

Related article:  Base Editing: New CRISPR technique could improve ability to safely edit human embryos

Olmem said the effort to streamline agricultural biotechnology could serve as a model other areas of biotech sectors.

Read full, original article: White House looks to clear path for ‘bioeconomy’

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend